doi : 10.1016/S2405-500X(22)01102-1
Volume 9, Issue 1, January 2023, Pages A6-A15
Joshua Hawson, MBBS, a,b Ahmed Al-kaisey, MBBS, a,b Robert D. Anderson, MBBS, BS C, P HD, a,b David Chieng, MBBS,b,c Louise Segan, MBBS,b,c Troy Watts, BS C, a Timothy Campbell, BSC ,d Joseph Morton, MBBS, PH D, a Alexander McLellan, MBBS, P HD, a Paul Sparks, MBBS, PH D, a Adam Lee, MBBS, PH D, e Edward P. Gerstenfeld, MD,f Henry H. Hsia, MD, e Aleksander Voskoboinik, MBBS, PH D, b,c Sandeep Prabhu, MMBS, P HD, c Bhupesh Pathik, MBBS, PHD, a Saurabh Kumar, BS C (M ED ), MBBS, PHD, d,f Peter Kistler, MBBS, PH D, b,c Jonathan Kalman, MBBS, PHD, a,b Geoffrey Lee, MBC HB, PH D
doi : 10.1016/j.jacep.2022.10.025
Volume 9, Issue 1, January 2023, Pages 1-16
Accurate annotation of local activation time is crucial in the functional assessment of ventricular tachycardia (VT) substrate. A major limitation of modern mapping systems is the standard prospective window of interest (sWOI) is limited to 490 to 500 milliseconds, preventing annotation of very late potentials (LPs). A novel retrospective window of interest (rWOI), which allows annotation of all diastolic potentials, was used to assess the functional VT substrate.
Michael Ghannam, MD, Jackson J. Liang, DO, Rakesh Latchamsetty, MD, Thomas Crawford, MD, Krit Jongnarangsin, MD, Fred Morady, MD, Frank Bogun, MD
doi : 10.1016/j.jacep.2022.08.034
Volume 9, Issue 1, January 2023, Pages 17-25
The characteristics of patients with post-myocardial infarction (PMI) ventricular tachycardia (VT) who require right ventricular (RV) ablation are underreported.
Nilesh Mathuria, MD
doi : 10.1016/j.jacep.2022.10.020
Volume 9, Issue 1, January 2023, Pages 26-27
Stephanie C. Fuentes Rojas, MD,a Maan Malahfji, MD, a Liliana Tavares, MD,a Apoor Patel, MD, a Paul A. Schurmann, MD,a Amish S. Dave, MD, PHD, a Carlos Tapias, MD,b Diego RodrÃguez, MD,b Luis Carlos Sáenz, MD,b Sergey Korolev, MD, c Giorgi Papiashvili, MD, P HD, d Petr Peichl, MD, e Josef Kautzner, MD, e Krzysztof Blaszyk, MD, PH D, f Katarzyna Malaczynska-Rajpold, MD, P HD, g Tiffany Chen, MD,h Pasquale Santangeli, MD,h Dipan J. Shah, MD, a Miguel Valderrábano, MD
doi : 10.1016/j.jacep.2022.08.035
Volume 9, Issue 1, January 2023, Pages 26-27
Mikael Laredo, MD, MSC , Estelle Gandjbakhch, MD, PHD
doi : 10.1016/j.jacep.2022.10.011
Volume 9, Issue 1, January 2023, Pages 40-42
Shunsuke Miyauchi, MD, PH D, a,b Hiromi Nishi, DDS, PH D, c Kazuhisa Ouhara, DDS, PHD, d Takehito Tokuyama, MD, PH D, a Yousaku Okubo, MD, PH D, a Sho Okamura, MD, PH D, a Shogo Miyamoto, MD,a Naoto Oguri, MD, a Yukimi Uotani, MD, a Taiichi Takasaki, MD, P HD, e Keijiro Katayama, MD, PHD, e Hisako Furusho, DDS, P HD, f Mutsumi Miyauchi, DDS, P HD, f Shinya Takahashi, MD, PHD, e Toru Hiyama, MD, P HD, b Yukiko Nakano, MD, P HD a
doi : 10.1016/j.jacep.2022.08.018
Volume 9, Issue 1, January 2023, Pages 43-53
Andreas Goette, MD
doi : 10.1016/j.jacep.2022.09.013
Volume 9, Issue 1, January 2023, Pages 54-56
Taylor S. Howard, MD,a, * David Y. Chiang, MD, PH D, b, * Scott R. Ceresnak, MD,c Virginie Beausejour Ladouceur, MD, d Robert D. Whitehill, MD, e Richard J. Czosek, MD, f Timothy K. Knilans, MD, f Agnethe M. Ahnfeldt, MD, g Malene Lando Borresen, MD, g Edgar Jaeggi, MD,d Sharmila Udupa, MD,h Robert Gow, MBBS, h Jeremy P. Moore, MD,i,j Roberto G. Galloti, MD, k Doug Y. Mah, MD, l Jeffrey J. Kim, MD, a Santiago O. Valdes, MD, a Dianna M. Milewicz, MD, m Christina Y. Miyake, MD, MS
doi : 10.1016/j.jacep.2022.08.022
Volume 9, Issue 1, January 2023, Pages 57-69
Atrial standstill (AS) is a rare condition characterized by absence of electrical activity within the atria. Studies to date have been limited.
Reina Bianca M. Tan, MD,a Therese M. Giglia, MD,b Frank Cecchin, MD a
doi : 10.1016/j.jacep.2022.11.025
Volume 9, Issue 1, January 2023, Pages 70-72
Christopher M. Janson, MD, CCDS, CEPS-P, a,b Maully J. Shah, MBBS, FHRS, CCDS, CEPS-P, a,b Kevin F. Kennedy, MS, c V. Ramesh Iyer, MD, MRCP, a,b Shashank Behere, MD, d Tammy L. Sweeten, MS,a,b Michael L. O’Byrne, MD, MSCE
doi : 10.1016/j.jacep.2022.08.023
Volume 9, Issue 1, January 2023, Pages 73-84
Guidelines for electrophysiology study (EPS) and catheter ablation in Wolff-Parkinson-White (WPW) are age based, but size may be a more relevant factor in determination of outcomes.
Roman Piotrowski, MD, PH D, Jakub Baran, MD, PHD, Agnieszka Sikorska, MD, P HD, Tomasz Krynski, MD, Piotr Kulakowski, MD, PH D
doi : 10.1016/j.jacep.2022.08.011
Volume 9, Issue 1, January 2023, Pages 85-95
Treatment of cardioinhibitory vasovagal syncope (VVS) is difficult. Recently, cardioneuroablation (CNA) has emerged as a new therapeutic option.
Boris Schmidt, MD,a Jens Erik Nielsen-Kudsk, MD, DMS C,b Christopher R. Ellis, MD,c David Thaler, MD, P HD, d Sajjad A. Sabir, MD, e Alok Gambhir, MD, PHD, f Ulf Landmesser, MD,g Neeraj Shah, MD,h William Gray, MD, i Vijendra Swarup, MD,j D. Scott Lim, MD, k Konstantinos Koulogiannis, MD, l Jordan A. Anderson, PHD, m Ryan Gage, MS,m Dhanunjaya Lakkireddy, MD n
doi : 10.1016/j.jacep.2022.07.014
Volume 9, Issue 1, January 2023, Pages 96-107
Device-related thrombus (DRT) following left atrial appendage occlusion (LAAO) can lead to adverse clinical outcomes. DRT rates and outcomes from randomized trials are limited.
Daniel J. Friedman, MD, a,b Jonathan P. Piccini, MD, MHS
doi : 10.1016/j.jacep.2022.11.029
Volume 9, Issue 1, January 2023, Pages 108-110
Sandeep K. Goyal, MD,a Syed Hyder, BS, a Shizhen Liu, MD, P HD, b Mani A. Vannan, MBBS
doi : 10.1016/j.jacep.2022.10.026
Volume 9, Issue 1, January 2023, Pages 111-116
Percutaneous left atrial appendage occlusion (LAAO) is contraindicated in presence of left atrial appendage (LAA) thrombus. It is often difficult to separate LAA sludge from an organized thrombus on transesophageal echocardiography.
Ahran D. Arnold, MBBS, PhD Matthew J. Shun-Shin, BMBCh, PhD Nadine Ali, BMBCh Daniel Keene, MBChB, PhD James P. Howard, MB BChir, PhD Darrel P. Francis, MB BChir, MD *Zachary I. Whinnett, BM, BS, PhD
doi : 10.1016/j.jacep.2022.07.024
Volume 9, Issue 1, January 2023, Pages 117-119
John Whitaker, BM, BCh, PhD Jeremy Bredfeldt, PhD Steven E. Williams, MBBS, PhD Pierre Qian, MBBS, PhD David Chang, MD Raymond H. Mak, MD Hubert Cochet, MD, PhD William Sauer, MDPaul C. Zei, MD, PhD *Usha Tedrow, MD, MSc
doi : 10.1016/j.jacep.2022.08.032
Volume 9, Issue 1, January 2023, Pages 119-121
Sanghamitra Mohanty, MD Carola Gianni, MD, PhD Angel Mayedo, MD Bryan MacDonald, MD Amin Al-Ahmad, MD Mohamed Bassiouny, MD G. Joseph Gallinghouse, MD Rodney Horton, MD John D. Burkhardt, MD *Andrea Natale, MD
doi : 10.1016/j.jacep.2022.08.028
Volume 9, Issue 1, January 2023, Pages 121-123
Christian Krijger Juárez, BS C,a Ahmad S. Amin, MD, PHD, b Joost A. Offerhaus, MD, a Connie R. Bezzina, P HD, a Bastiaan J. Boukens, PHD
doi : 10.1016/j.jacep.2022.09.017
Volume 9, Issue 1, January 2023, Pages 124-138
Abnormal cardiac repolarization is at the basis of life-threatening arrhythmias in various congenital and acquired cardiac diseases. Dysfunction of ion channels involved in repolarization at the cellular level are often the underlying cause of the repolarization abnormality.
Shunmuga Sundaram Ponnusamy, MD, DM,a Sabari Saravanan, BE,b William Basil, BE, c Pugazhendhi Vijayaraman, MD
doi : 10.1016/j.jacep.2022.09.010
Volume 9, Issue 1, January 2023, Pages 139-141
Xueying Chen, MD, a,b, * Hao Lu, MD,a,b, * Lili Xu, MD, a,b, * Haiyan Chen, MD, a,b Ye Xu, MD, a,b Shikun Xu, MD, a,b Qibing Wang, MD,a,b Juying Qian, MD, a,b Junbo Ge, MD
doi : 10.1016/j.jacep.2022.09.009
Volume 9, Issue 1, January 2023, Pages 142-144
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟